nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Active Surveillance for Intermediate-risk Prostate Cancer: A Systematic Review, Meta-analysis, and Metaregression
|
Baboudjian, Michael |
|
|
5 |
6 |
p. 617-627 |
artikel |
2 |
Adjuvant Systemic Therapy for High-risk Muscle-invasive Bladder Cancer After Radical Cystectomy: Current Options and Future Opportunities
|
Mir, M. Carmen |
|
|
5 |
6 |
p. 726-731 |
artikel |
3 |
A Multivariable Approach Using Magnetic Resonance Imaging to Avoid a Protocol-based Prostate Biopsy in Men on Active Surveillance for Prostate Cancer—Data from the International Multicenter Prospective PRIAS Study
|
Luiting, Henk Benjamin |
|
|
5 |
6 |
p. 651-658 |
artikel |
4 |
Contents
|
|
|
|
5 |
6 |
p. iii-v |
artikel |
5 |
Editorial Board
|
|
|
|
5 |
6 |
p. i-ii |
artikel |
6 |
Epidemiology, Screening, and Prevention of Bladder Cancer
|
Lobo, Niyati |
|
|
5 |
6 |
p. 628-639 |
artikel |
7 |
Immune Biomarkers in Metastatic Castration-resistant Prostate Cancer
|
Fenor de la Maza, María Dolores |
|
|
5 |
6 |
p. 659-667 |
artikel |
8 |
Predicting Oncologic Outcomes in Small Renal Tumors
|
Kapur, Payal |
|
|
5 |
6 |
p. 687-694 |
artikel |
9 |
Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography–based Lymph Node Atlas for Salvage Radiotherapy in Patients with Recurrent Prostate Cancer: A Validation of the New NRG Oncology 2020 guideline
|
Vogel, Marco M.E. |
|
|
5 |
6 |
p. 668-676 |
artikel |
10 |
Quality Goal for Salvage Treatment for Patients with Prostate Cancer at Prostate-specific Antigen Relapse
|
von Eyben, Rie |
|
|
5 |
6 |
p. 732-733 |
artikel |
11 |
Selecting the Best Candidates for Cisplatin-based Adjuvant Chemotherapy After Radical Cystectomy Among Patients with pN+ Bladder Cancer
|
Afferi, Luca |
|
|
5 |
6 |
p. 722-725 |
artikel |
12 |
Sentinel Node Identification with Hybrid Tracer-guided and Conventional Dynamic Sentinel Node Biopsy in Penile Cancer: A Prospective Study in 130 Patients from the Two National Referral Centres in Sweden
|
Torbrand, Christian |
|
|
5 |
6 |
p. 704-711 |
artikel |
13 |
Somatic Features of Response and Relapse in Non–muscle-invasive Bladder Cancer Treated with Bacillus Calmette-Guérin Immunotherapy
|
Bacon, Jack V.W. |
|
|
5 |
6 |
p. 677-686 |
artikel |
14 |
Stereotactic Ablative Radiation for Systemic Therapy–naïve Oligometastatic Kidney Cancer
|
Hannan, Raquibul |
|
|
5 |
6 |
p. 695-703 |
artikel |
15 |
Three-dimensional Model–assisted Minimally Invasive Partial Nephrectomy: A Systematic Review with Meta-analysis of Comparative Studies
|
Piramide, Federico |
|
|
5 |
6 |
p. 640-650 |
artikel |
16 |
Towards a Better Understanding of Antibody-Drug Conjugates in Urothelial Carcinoma
|
Labaki, Chris |
|
|
5 |
6 |
p. 719-721 |
artikel |
17 |
Treatments for Metastatic Hormone-sensitive Prostate Cancer: Systematic Review, Network Meta-analysis, and Benefit-harm assessment
|
Menges, Dominik |
|
|
5 |
6 |
p. 605-616 |
artikel |
18 |
TROP2 Expression Across Molecular Subtypes of Urothelial Carcinoma and Enfortumab Vedotin-resistant Cells
|
Chou, Jonathan |
|
|
5 |
6 |
p. 714-718 |
artikel |
19 |
Will Dynamic Sentinel Lymph Node Biopsy Surpass Inguinal Lymph Node Dissection in High-risk Node-negative Penile Cancer?
|
Peak, Taylor |
|
|
5 |
6 |
p. 712-713 |
artikel |